≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

ILD medications: pirfenidone

Endpoint Browser

ILD_PIRFENIDONE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Medicine purchases: ATC — L04AX05

1 out of 7 registries used, show all original rules.

315

4. Check minimum number of events

Min. number of events 3
315

5. Include endpoints

None

315

6. Filter based on genotype QC (FinnGen only)

315

Control definitions (FinnGen only)

Control exclude
ILD_MEDICATIONS

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 315 82 233
Unadjusted period prevalence (%) 0.08 0.03 0.10
Median age at first event (years) 71.73 71.86 71.68

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
274
Matched controls
2741
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
12580.8
323.0
272
23
L04AX05
ATC
pirfenidone; oral
+∞
323.0
274
*
284
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
323.0
272
*
356
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
293.1
226
*
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
165.3
162.0
160
23
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
50.4
105.1
127
46
L01XE31
ATC
[U] nintedanib; oral
+∞
75.6
69
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
39.6
73.4
93
35
UGC12
NOMESCO Finland
Flexible bronchoscopy
17.5
71.2
122
120
H02AB06
ATC
prednisolone; systemic
9.9
65.4
192
525
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
41.2
64.0
80
27
TGC00
NOMESCO Finland
Bronchial lavation
50.1
61.9
74
20
GD1AA
NOMESCO Finland
Thorax X-ray examination
8.5
51.7
225
958
XG410
NOMESCO Finland
Flow-volume spirometry
21.6
46.0
69
42
R03AC02
ATC
salbutamol; inhalant
6.6
45.3
197
767
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
14.7
39.6
69
61
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
9.0
39.2
92
146
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
435.0
39.1
38
*
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
27.6
37.9
52
23
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
137.5
34.6
36
*
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
137.5
34.6
36
*
GDG10
NOMESCO Finland
Bilateral transplantation of lung
+∞
30.8
29
*
Z94.2
ICD-10 Finland
Lung transplant status
+∞
30.8
29
*
L04AA06
ATC
mycophenolic acid; systemic
+∞
30.8
29
*
R06.0
ICD-10 Finland
Dyspnoea
4.9
29.8
127
414
127
Kela drug reimbursment
Transplant complication
+∞
29.7
28
*
L01EX09
ATC
nintedanib; oral
+∞
28.6
27
*
Z51.5
ICD-10 Finland
Palliative care
9.0
28.5
64
90
R05
ICD-10 Finland
Cough
5.0
26.2
100
282
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
8.1
26.1
62
95
J96.1
ICD-10 Finland
Chronic respiratory failure
25.7
26.0
36
16
GD1AD
NOMESCO Finland
Thorax CT examination
9.6
25.8
55
70
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.4
25.4
114
378
R4110
NOMESCO Finland
Physiotherapy
3.9
23.1
126
487
L04AX01
ATC
azathioprine; systemic
+∞
22.2
21
*
R03BA08
ATC
ciclesonide; inhalant
9.6
21.5
45
55
A02BC02
ATC
pantoprazole; systemic
3.9
21.4
216
1345
L04AD01
ATC
ciclosporin; systemic
+∞
21.1
20
*
R03BB04
ATC
tiotropium bromide; inhalant
6.4
20.4
57
108
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.7
20.2
111
422
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
13.7
19.2
33
27
XX4BW
NOMESCO Finland
NA
+∞
19.0
18
*
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
+∞
19.0
18
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
10.1
18.9
38
43
R28
ICPC
Limited function/disability (R)
41.6
18.9
23
6
WX721
NOMESCO Finland
Oxygen concentrator therapy
+∞
17.9
17
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.3
17.8
74
217
J45.9
ICD-10 Finland
Asthma, unspecified
5.4
17.4
56
125
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
3.1
16.3
122
564
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
26.4
16.3
22
9
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.4
16.0
63
174
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
28.3
15.8
21
8
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.6
15.8
84
302
R05
ICPC
Cough
3.4
15.2
88
336
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
33.9
15.0
19
6
N02AA01
ATC
morphine; systemic, rectal
29.0
14.5
19
7
R99
ICPC
Respiratory disease other
15.6
14.3
23
16
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
31.9
14.1
18
6
J01AA02
ATC
doxycycline; systemic
3.2
14.0
226
1637
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.7
13.5
148
840
XG466
NOMESCO Finland
Sleep oxymetry
8.5
13.0
28
36
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
12.8
109
528
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.8
12.7
32
52
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.0
12.4
87
373
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.1
12.1
79
320
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.4
11.9
44
113
WX892
NOMESCO Finland
Monitored bed care
4.2
11.6
46
126
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.0
11.6
38
86
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
125.0
11.5
12
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
12.7
11.0
19
16
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.4
10.8
40
103
D07AB02
ATC
hydrocortisone butyrate; topical
2.7
10.7
92
438
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
9.8
10.7
21
23
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
+∞
10.5
10
*
M05BA04
ATC
alendronic acid; oral
5.1
10.4
33
72
G47.3
ICD-10 Finland
Sleep apnoea
2.7
10.1
82
378
XJC10
NOMESCO Finland
Oesophageal pH monitoring
41.7
10.0
12
*
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.7
10.0
34
80
J01CA04
ATC
amoxicillin; systemic
2.5
10.0
211
1572
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
3.2
9.9
56
205
N02BE01
ATC
paracetamol; systemic, rectal
3.1
9.8
243
1971
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
8.0
9.6
21
28
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.5
9.6
94
478
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.5
9.6
90
448
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
6.9
9.5
23
36
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
+∞
9.4
9
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
9.4
9
*
N02AX02
ATC
tramadol; systemic, rectal
2.3
9.3
133
809
R4190
NOMESCO Finland
Nutritional therapy
6.5
9.1
23
38
J01FA06
ATC
roxithromycin; oral
2.3
9.1
107
593
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
9.1
122
721
M05BA07
ATC
risedronic acid; oral
8.1
8.8
19
25
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.2
8.8
134
836
R03AK07
ATC
formoterol and budesonide; inhalant
3.2
8.8
48
170
J01MA14
ATC
moxifloxacin; systemic
4.0
8.5
34
94
R02
ICPC
Shortness of breath/dyspnoea
3.2
8.2
43
149
J45.1
ICD-10 Finland
Nonallergic asthma
6.2
8.2
21
36
J45.0
ICD-10 Finland
Predominantly allergic asthma
6.2
8.2
21
36
R03DC03
ATC
montelukast; oral
3.6
8.2
36
109
N02AA05
ATC
oxycodone; systemic
2.7
8.0
58
247
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.1
8.0
30
79
J01FA10
ATC
azithromycin; systemic
2.1
7.7
136
884
R5140
NOMESCO Finland
Monitoring the use of the aid
3.0
7.6
46
173
SPAT1325
SPAT
Vaccination
2.1
7.4
124
783
E0000UV
ATC
NA
2.1
7.4
104
613
A02BC05
ATC
esomeprazole; systemic
2.1
7.4
120
753
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.3
7.3
37
125
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
16.3
7.3
11
7
ZX108
NOMESCO Finland
Inhalation
30.9
7.2
9
*
R03AK08
ATC
formoterol and beclometasone; inhalant
9.2
7.1
14
16
J47
ICD-10 Finland
Bronchiectasis
10.4
7.1
13
13
A98
ICPC
Health maint/preventive medicine
4.5
7.0
265
2379
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
6.9
177
1311
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
41.1
6.8
8
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.9
6.7
42
163
R2110
NOMESCO Finland
Giving the first information
4.1
6.7
25
66
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
6.6
62
300
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
7.7
6.5
14
19
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
71.4
6.5
7
*
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
71.4
6.5
7
*
SAA03
NOMESCO Finland
Extended examination of mouth
2.0
6.4
100
608
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
18.5
6.3
9
5
SPAT1262
SPAT
Handing over of treatment supplies
2.2
6.3
70
368
2AX04
NOMESCO Finland
NA
+∞
6.3
6
*
5AB14
NOMESCO Finland
NA
+∞
6.3
6
*
WX726
NOMESCO Finland
High-flow oxygen therapy
+∞
6.3
6
*
R03BA02
ATC
budesonide; inhalant
2.9
6.3
39
150
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.3
6.3
30
98
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.9
6.2
123
816

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037522) Nuclear Ab [Titer] in Serum
175
207
17.77
152.55
1.4
1.2
titre
352.7
378.6
0.06
55
43
(3000492) Spirometry study
144
191
13.05
112.41
4.0
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
62
12
64.08
110.29
3.9
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
168
284
11.53
108.27
1.3
1.2
iu/ml
52.7
22.3
1.46
44
71
(3019060) Gas panel - Arterial blood
143
206
11.88
104.16
4.8
5.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
79
45
23.10
100.75
3.8
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
78
45
22.71
98.83
3.9
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
56
12
56.54
97.28
4.3
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
63
24
32.56
93.74
3.7
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
70
40
22.21
88.74
3.7
1.2
—
—
—
0
0
(4010399)
123
185
10.27
85.01
2.4
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
64
34
23.37
83.62
2.8
1.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
253
841
11.20
83.60
11.4
3.1
u/l
28.8
34.2
2.55
253
789
(3006184) Hemoglobin [Mass/volume] in Capillary blood
76
60
16.38
81.54
2.0
2.6
g/l
143.8
130.1
1.36
15
46
(42870588) Differential panel, method unspecified - Blood
243
797
9.96
80.40
15.2
3.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
55
22
30.08
80.12
3.4
1.2
—
—
—
0
0
(44806118)
58
28
25.16
78.71
4.4
1.3
—
—
—
0
0
(44790049)
58
28
25.16
78.71
4.4
1.3
—
—
—
0
0
(44790048)
58
28
25.16
78.71
4.4
1.3
—
—
—
0
0
(44790047)
58
28
25.16
78.71
4.4
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
291
1174
20.41
78.28
14.1
3.6
e9/l
0.7
0.6
6.13
270
975
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
60
32
22.93
78.09
3.6
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
295
1212
23.59
77.91
15.3
3.7
e9/l
0.3
0.2
4.40
277
1037
(3006315) Basophils [#/volume] in Blood
291
1181
20.22
77.56
14.1
3.6
e9/l
0.0
0.0
3.81
270
992
(3019198) Lymphocytes [#/volume] in Blood
290
1195
18.98
75.28
14.3
3.7
e9/l
2.0
2.0
0.12
269
1022
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
74
64
14.81
75.04
3.6
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
130
249
8.19
71.67
1.1
1.2
u/ml
22.8
2.2
0.99
26
82
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
86
102
11.22
70.51
4.9
2.7
—
—
—
0
0
(4306422)
52
25
24.71
70.46
1.3
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
159
384
7.34
69.69
12.1
8.0
mmol/l
1.5
1.1
1.04
136
303
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
55
32
20.61
68.59
1.4
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
136
308
7.01
62.76
3.8
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
295
1407
18.27
60.59
17.7
7.3
e9/l
4.8
4.2
4.41
280
1213
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
134
313
6.71
59.51
3.9
1.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
297
1441
19.57
59.50
21.7
6.1
umol/l
9.5
13.2
8.69
297
1367
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
63
62
12.45
58.33
1.6
1.4
titre
176.7
—
—
6
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
35
10
39.25
56.00
1.1
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
35
10
39.25
56.00
2.2
2.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
46
29
18.40
54.88
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
50
39
15.05
53.25
2.0
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
45
30
17.33
52.13
1.2
1.1
u/ml
3.2
2.5
0.29
28
11
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
152
442
5.71
52.03
4.0
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
46
33
16.15
51.25
2.1
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
44
30
16.89
50.34
3.5
3.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
42
29
16.56
47.67
1.2
1.1
u/ml
1.6
1.3
—
13
9
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
57
66
10.32
46.75
3.7
2.1
%
202.5
210.0
0.18
57
61
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
37
28
14.84
39.78
1.1
1.0
u/ml
441.5
253.9
1.59
28
12
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
37
29
14.32
38.97
1.1
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
43
43
11.42
38.90
1.4
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
81
170
6.07
38.77
16.4
11.4
mmol/l
25.0
24.5
0.83
75
159
(3021879) Hepatitis B virus core Ab [Presence] in Serum
63
107
7.11
37.18
1.3
1.4
—
—
—
0
0
(4268621)
31
19
17.99
37.13
2.1
2.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
31
21
16.26
35.27
3.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
39
39
11.27
35.20
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
31
22
15.52
34.40
3.1
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
154
617
3.93
31.67
12.2
5.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
179
814
3.78
30.03
6.0
3.3
ph
7.4
7.4
1.21
29
136
(3023368) Bacteria identified in Blood by Culture
180
823
3.77
29.92
5.4
4.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
35
8
49.00
29.35
1.1
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
31
29
11.75
29.11
5.5
1.7
e9/l
5.0
4.6
0.26
31
29
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
93
276
4.36
28.85
4.7
2.9
ng/l
141.2
192.1
0.93
87
255
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
35
9
43.46
28.70
1.1
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
22
11
21.43
28.66
1.4
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
48
80
6.90
28.57
1.3
1.7
u/l
38.5
42.5
0.45
41
64
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
30
11.35
28.45
5.6
1.8
%
57.3
59.5
0.30
31
30
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
232
1280
4.08
28.42
12.7
5.7
mmol/l
1.2
1.2
1.99
226
1138
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
128
482
3.79
28.28
2.5
1.6
mg/l
1.8
1.3
0.40
107
384
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
196
972
3.69
28.22
4.0
2.8
ng/l
1141.0
1442.8
0.58
180
844
(3005322) IgE [Units/volume] in Serum or Plasma
50
92
6.27
26.97
1.1
1.1
u/ml
216.9
124.6
1.00
45
80
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
31
6
57.06
26.74
1.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
70
178
4.77
26.29
1.4
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
74
201
4.50
25.54
1.4
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
32
40
8.79
24.32
1.1
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
208
1137
3.44
24.31
19.7
8.2
e9/l
0.0
0.0
1.28
185
920
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
19
10
20.16
24.11
2.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
38
8.94
23.92
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
29
33
9.58
23.67
4.3
2.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
68
186
4.39
23.12
1.3
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
232
1380
3.59
23.10
13.2
6.2
mmol/l
1.2
1.2
0.35
214
1162
(3017181) Myelocytes/100 leukocytes in Blood
64
172
4.41
22.22
6.8
3.2
%
0.3
0.9
1.53
25
51
(3037692) Legionella sp identified in Specimen by Organism specific culture
27
7
41.94
22.10
4.4
1.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
59
151
4.58
21.78
6.9
2.9
%
0.8
0.3
0.38
20
34
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
65
185
4.17
20.85
21.8
10.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
12
15.85
20.36
2.1
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
12
15.85
20.36
2.6
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
57
151
4.39
20.06
5.9
3.2
%
0.0
0.0
0.48
22
38
(40760892) CBC W Ordered Manual Differential panel - Blood
109
453
3.15
19.46
11.7
3.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
310
2576
13.81
18.84
34.5
13.9
mg/l
22.9
28.4
3.22
295
2013
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
67
212
3.74
18.39
1.7
1.7
%
1.6
1.7
1.02
61
161
(3018677) aPTT in Platelet poor plasma by Coagulation assay
110
475
3.02
18.19
3.0
1.8
s
29.2
29.7
0.35
110
462
(1616796) Gas panel - Central venous blood
33
59
6.13
18.14
6.6
2.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
22
6
39.24
17.85
4.7
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
58
170
3.96
17.73
4.7
3.4
mmol/l
2.6
1.9
0.88
44
135
(3024561) Albumin [Mass/volume] in Serum or Plasma
204
1237
2.84
17.45
8.0
4.6
g/l
33.9
35.0
2.15
196
1145
(3019832) Treponema pallidum Ab [Presence] in Serum
31
55
6.14
17.16
1.2
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
123
583
2.82
16.93
5.1
3.7
ng/l
735.6
390.6
0.84
115
501
(3009343) pH of Capillary blood
58
178
3.77
16.55
5.5
3.4
ph
7.4
7.4
—
8
23
(3020891) Body temperature
50
141
4.03
16.06
5.0
4.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
15
11
14.27
16.02
1.0
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
80
310
3.12
15.75
5.4
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
108
502
2.75
15.17
5.0
3.0
e6/l
1.1
1.3
0.17
70
290
(3021440) Promyelocytes/100 leukocytes in Blood
53
164
3.68
14.88
6.4
3.2
%
0.1
0.2
0.11
23
44
(36304419) Bacteria [Presence] in Urine
144
778
2.57
14.84
6.0
3.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
153
858
2.52
14.47
5.5
2.0
u/l
132.9
297.7
1.12
148
798
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
19
7
28.74
14.45
2.0
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
39
6.58
14.42
1.7
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
39
6.58
14.42
1.7
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
148
825
2.50
14.09
5.9
3.1
e6/l
0.5
0.5
0.12
123
617
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
18
6
31.68
14.03
2.1
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
201
1301
2.51
13.62
13.5
11.1
inr
1.3
1.4
0.55
58
346
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
30
64
5.08
13.60
2.9
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
108
527
2.60
13.54
4.8
2.9
e6/l
0.6
1.0
1.15
73
310
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
40
113
3.91
12.74
3.6
2.5
u/ml
0.3
0.4
0.55
19
60
(3043409) Potassium [Moles/volume] in Arterial blood
40
113
3.91
12.74
5.0
3.8
mmol/l
4.0
4.0
0.24
40
102
(3007164) IgA [Mass/volume] in Serum or Plasma
87
392
2.68
12.72
2.3
1.3
g/l
3.1
2.8
0.68
73
206
(4062490)
13
11
12.28
12.71
1.1
1.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
239
1712
2.64
12.49
13.8
4.8
mmol/l
6.9
6.9
0.04
230
1613
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
174
1086
2.35
12.36
6.4
3.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
114
593
2.45
12.28
4.4
3.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
38
108
3.86
11.99
5.6
2.3
ug/l
575.1
1017.6
0.41
38
102
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
20
8.37
11.99
1.3
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
20
8.37
11.99
1.3
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
20
8.37
11.99
1.3
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
151
896
2.32
11.96
6.4
3.2
e6/l
34.5
119.7
0.61
126
686
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
16
7
23.97
11.68
2.8
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
27
61
4.75
11.43
3.6
2.4
%
17.1
16.4
0.32
14
32
(3022313) Gas panel - Capillary blood
41
127
3.56
11.41
6.0
3.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
51
183
3.13
11.23
1.9
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
244
1808
2.55
11.13
7.2
3.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
47
163
3.21
10.94
1.6
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
159
997
2.20
10.66
7.8
3.7
e6/l
76.5
76.0
0.00
130
725
(3024980) IgG subclass 4 [Mass/volume] in Serum
15
20
7.83
10.65
1.1
1.1
g/l
0.6
0.7
—
9
15
(3026493) Urate [Moles/volume] in Serum or Plasma
121
681
2.26
10.59
10.1
2.5
umol/l
341.5
10213.6
3.74
108
555
(3015377) Calcium [Moles/volume] in Serum or Plasma
152
939
2.20
10.55
6.7
3.2
mmol/l
2.3
2.3
0.44
142
808
(3026782) Osmolality of Urine
108
582
2.30
10.46
4.6
2.7
mosm/kgh2o
601.6
589.6
0.24
98
483
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
15
8
19.60
10.36
1.2
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
14
18
8.09
10.22
3.1
2.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
68
302
2.60
10.04
3.0
2.5
umol/l
12.2
11.5
0.06
61
272
(3028626) Oxygen [Partial pressure] in Capillary blood
26
65
4.27
9.71
5.6
2.7
kpa
7.8
8.0
0.27
26
60
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
170
1125
2.11
9.59
3.0
2.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
184
1262
2.10
9.35
7.0
4.7
estimate
0.0
0.0
0.00
35
227
(3000991) Gas panel - Venous blood
63
280
2.56
9.24
20.4
9.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
184
1273
2.07
9.00
5.0
3.6
estimate
0.0
0.0
0.00
33
225
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
5
24.86
8.97
1.1
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
5
24.86
8.97
1.1
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
5
24.86
8.97
1.1
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
5
24.86
8.97
1.1
1.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
185
1285
2.07
8.92
5.0
3.5
estimate
0.0
0.0
0.00
34
213
(3022806) Fractional oxyhemoglobin in Capillary blood
17
33
5.39
8.50
2.5
1.4
%
88.2
89.5
0.32
17
33
(3042936) Bacteria identified in Isolate by Culture
79
403
2.28
8.50
5.0
2.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
16
7.76
8.47
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
16
7.76
8.47
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
16
7.76
8.47
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
16
7.76
8.47
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
16
7.76
8.47
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
16
7.76
8.47
1.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
9
15.00
8.27
1.2
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
105
607
2.09
8.22
4.6
2.5
e6/l
2.5
3.7
2.15
97
521
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
20
6.74
8.13
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
22
57
4.07
7.84
4.7
2.8
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
11
6
18.93
7.65
1.0
1.0
%
107.4
104.7
—
11
6
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
44
180
2.68
7.57
1.8
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
7
16.21
7.28
6.7
3.1
—
—
—
0
0
(3044889) 12 lead EKG panel
251
2032
2.16
7.07
7.8
4.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
27
87
3.30
7.05
4.0
2.7
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
10
6
17.16
6.79
1.6
1.0
%
218.1
157.7
—
10
6
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
140
948
1.86
6.63
3.2
2.0
nmol/l
67.6
77.2
5.68
133
798
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
30
108
2.96
6.52
5.3
3.6
mmol/l
25.4
25.2
0.21
30
98
(3012544) pH of Venous blood
60
303
2.21
6.50
2.6
3.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
58
290
2.23
6.43
2.6
3.5
mmol/l
2.8
1.8
0.88
48
229
(3009542) Hematocrit [Volume Fraction] of Blood
266
2240
2.21
6.19
42.6
16.7
%
39.1
39.3
0.15
187
1358
(40761511) CBC panel - Blood by Automated count
303
2717
4.02
6.10
26.9
14.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
14
32
4.53
5.82
1.4
1.3
iu/ml
415.1
0.2
—
8
6
(40768797) Stomach Pathology biopsy report
64
359
1.98
5.21
1.3
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
105
691
1.78
5.20
1.6
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
46
3.61
4.96
1.4
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
11
24
4.71
4.82
5.5
3.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
32
141
2.41
4.73
2.4
3.8
mmol/l
25.2
24.3
0.48
27
129
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
44
3.53
4.52
1.9
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
30
133
2.39
4.38
2.4
2.4
e9/l
4.2
3.8
0.61
24
93
(3008536) Aspergillus sp Ab [Presence] in Serum
7
6
11.89
4.29
1.3
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
153
1161
1.62
4.24
4.8
3.8
ng/l
51.4
45.8
0.15
128
920
(3051651) Icteric interference index of Serum or Plasma
9
13
7.09
4.19
5.9
3.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
113
798
1.65
4.17
3.3
3.1
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
8
10
8.17
4.08
1.0
1.8
%
71.6
66.8
—
8
10
(3029937) Albumin [Presence] in Urine by Test strip
105
734
1.65
4.01
4.9
3.8
estimate
0.0
0.0
0.00
33
212
(3019150) Specific gravity of Urine by Refractometry
88
591
1.68
3.90
5.0
4.0
kg/l
1.0
1.0
1.15
20
85
(3045788) Cell count panel - Pleural fluid
12
34
3.63
3.80
1.5
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
25
4.10
3.72
1.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
67
2.79
3.72
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
67
2.79
3.72
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
46
258
1.92
3.72
2.3
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
132
992
1.57
3.67
4.9
3.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
40
3.35
3.66
1.6
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
68
2.75
3.63
1.2
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
36
187
2.04
3.61
1.6
1.6
ug/g
122.6
128.9
0.06
31
149
(3028433) Virus identified in Specimen by Culture
6
6
10.16
3.51
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
50
793
0.56
3.50
3.3
3.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
132
1007
1.54
3.36
3.2
3.3
mg/l
37.9
161.4
0.95
94
666
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
117
872
1.54
3.30
3.4
2.5
u/l
63.5
57.7
1.06
112
804
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
11
6.48
3.20
1.0
2.2
—
—
—
0
0
(4015189)
6
8
7.62
3.06
1.7
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
38
214
1.88
3.05
3.1
2.9
ml/min/173m2
53.9
60.7
0.47
15
83
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
186
1548
1.49
3.00
7.8
3.0
u/l
57.6
62.5
0.37
178
1395
(3036481) Cortisol [Moles/volume] in Serum or Plasma
35
194
1.90
2.94
1.6
2.3
nmol/l
366.7
394.5
0.26
35
180
(21494815) CD4 cells/100 lymphocytes in Specimen
6
9
6.77
2.88
1.0
1.8
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
5
6
8.44
2.76
1.0
2.2
%
11.6
12.2
—
5
6
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
5
6
8.44
2.76
1.0
2.2
%
27.0
26.8
—
5
6
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
6
8.44
2.76
1.2
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
6
8.44
2.76
1.2
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
129
1012
1.47
2.74
3.2
3.1
mmol/l
7.6
8.0
0.44
112
818
(40768804) Tissue Pathology biopsy report
131
1031
1.46
2.73
2.7
2.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
55
2.62
2.65
1.6
1.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
15
4.75
2.61
1.1
1.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
57
378
1.62
2.60
1.9
2.5
%
22.2
23.7
0.32
44
315
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
25
3.67
2.59
1.0
1.0
u/ml
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
20
4.08
2.58
1.6
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
7
7.23
2.56
1.2
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
7
7.23
2.56
1.2
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
7
7.23
2.56
1.2
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
7
7.23
2.56
1.2
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
7
7.23
2.56
1.2
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
11
39
2.89
2.50
1.6
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
26
3.53
2.50
1.4
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
76
2.31
2.49
1.4
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
76
2.31
2.49
1.6
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
133
1066
1.43
2.45
4.1
4.0
mg/mmol
5.8
8.6
0.56
93
687
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
84
2.21
2.40
1.3
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
62
429
1.55
2.37
1.9
2.5
umol/l
13.4
13.2
0.09
62
388
(3024354) Oxygen [Partial pressure] in Venous blood
40
249
1.69
2.33
2.2
2.8
kpa
4.7
4.4
0.55
40
242
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
23
3.54
2.28
3.1
4.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
46
301
1.62
2.22
1.9
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
261
2388
1.54
2.21
4.3
4.3
mu/l
2.1
2.1
0.07
239
2091
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
89
682
1.43
2.05
2.7
2.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
111
887
1.39
2.01
2.7
2.4
—
—
—
0
0
(3004451) EKG impression Narrative
6
16
3.80
1.94
1.7
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
13
59
2.26
1.87
1.9
2.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
270
2517
1.51
1.79
31.4
14.5
ml/min/173m2
73.3
74.4
0.44
244
2046
(3037756) Immunofixation for Serum or Plasma
12
54
2.27
1.76
1.3
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
6
18
3.38
1.75
1.5
3.2
%
50.7
62.9
—
6
13
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
75
574
1.40
1.72
2.2
3.2
mmol/l
2.5
2.4
1.34
68
503
(21494434) Karyotype in Bone marrow
8
31
2.62
1.67
1.5
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
38
256
1.55
1.65
3.7
3.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
16
84
1.95
1.63
3.6
2.8
umol/l
30.3
36.5
0.87
16
73
(3023420) DNA double strand Ab [Units/volume] in Serum
5
14
3.61
1.62
1.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
39
267
1.53
1.58
3.1
2.2
e9/l
58.9
65.5
0.77
25
210
(3025941) Bacteria identified in Stool by Culture
20
115
1.79
1.56
1.4
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
84
669
1.35
1.51
4.7
3.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
150
1297
1.30
1.50
5.2
4.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
10
45
2.26
1.48
1.8
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
208
1883
1.31
1.45
3.4
3.4
pmol/l
14.1
15.0
5.66
190
1627
(3004588) Protein electrophoresis panel - Serum or Plasma
28
184
1.57
1.37
1.5
1.9
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
17
2.97
1.36
7.0
5.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
43
2.12
1.31
1.6
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
284
2712
1.48
1.26
5.9
5.8
mmol/l
2.5
2.6
0.91
266
2442
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
43
316
1.42
1.25
4.7
3.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
272
2579
1.40
1.25
7.2
6.9
mmol/mol
42.1
40.9
1.33
255
2345
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
26
2.33
1.19
2.5
2.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
129
0.45
1.19
1.2
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
10
50
2.03
1.17
1.4
1.3
mmol/l
65.6
59.2
—
10
43
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
104
1.67
1.12
2.4
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
31
2.29
1.11
1.3
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
27
381
0.68
1.10
4.4
5.1
%
30.0
31.7
0.54
21
237
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
95
809
1.25
1.01
1.9
1.7
mmol/l
1.6
1.3
2.63
85
640
(3044941) Cell count panel - Synovial fluid
7
35
2.02
1.00
1.6
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
12
69
1.77
0.98
2.8
1.4
mg/l
73.5
2.8
2.75
12
51
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
77
643
1.26
0.97
1.9
1.8
pmol/l
123881019.1
11004283.6
0.43
67
518
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
37
1.91
0.94
1.3
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
266
2539
1.31
0.94
4.6
4.5
mmol/l
1.4
1.3
2.49
242
2263
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
31
228
1.40
0.93
1.3
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
17
110
1.58
0.92
2.7
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
28
2.16
0.92
1.2
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
274
2630
1.32
0.89
5.1
5.0
mmol/l
1.4
1.4
0.68
251
2359
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
275
2649
1.30
0.80
5.2
5.1
mmol/l
4.3
4.4
0.30
252
2404
(3016018) Differential panel - Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
30
228
1.35
0.76
4.3
3.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
30
387
0.75
0.75
9.8
8.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
55
1.65
0.74
1.4
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
28
364
0.75
0.74
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
92
1.55
0.73
1.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
5
25
2.02
0.73
1.6
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
25
2.02
0.73
1.0
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
11
68
1.64
0.72
2.7
2.0
%
70.4
61.3
1.03
11
68
(4034850)
14
94
1.51
0.68
9.6
11.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
275
2663
1.26
0.65
5.6
5.3
mmol/l
6.2
6.2
0.23
256
2373
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
29
1.74
0.64
1.0
1.0
—
—
—
0
0
(4094501)
11
71
1.57
0.63
1.1
1.1
—
—
—
0
0
(4035726)
31
245
1.29
0.62
1.4
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
22
165
1.36
0.62
2.5
2.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
50
1.62
0.61
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
50
1.62
0.61
1.4
1.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(4281824)
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
6
36
1.68
0.57
4.3
5.5
mmol/l
8.2
6.5
—
6
28
(3045424) Erythrocytes [Presence] in Urine
6
40
1.51
0.52
2.2
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
7
108
0.64
0.49
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
35
293
1.22
0.46
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
21
263
0.78
0.45
4.0
3.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
23
184
1.27
0.45
5.6
2.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
6
92
0.65
0.43
1.0
1.2
—
137.1
—
0
33
(21494890) Protein electrophoresis panel - 24 hour Urine
5
33
1.52
0.41
1.0
2.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
15
0.00
0.41
0.0
1.7
—
3774.7
—
0
10
(3027944) Amphetamines [Presence] in Urine
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
16
0.00
0.41
0.0
1.1
—
308.4
—
0
10
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18
141
1.29
0.41
1.5
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
17
0.00
0.41
0.0
1.2
—
11.6
—
0
6
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
78
708
1.14
0.40
2.2
2.0
mg/l
2.8
3.0
0.32
70
597
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.3
—
35.1
—
0
5
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
36
1.40
0.38
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
133
1410
0.90
0.38
3.7
4.8
%
23.9
21.1
0.73
46
741
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
93
1005
0.89
0.37
2.6
3.3
ug/l
0.6
0.7
0.87
76
716
(3024928) Oxygen saturation in Venous blood
10
72
1.40
0.37
1.7
3.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
73
1.38
0.35
1.1
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
10
78
1.29
0.24
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
18
153
1.19
0.23
1.0
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
156
0.83
0.22
6.6
3.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
42
1.19
0.21
2.6
1.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
10
0.00
0.21
0.0
1.3
—
39.3
—
0
5
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(4027681)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
48.7
—
0
9
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
282.2
—
0
14
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
82
1.23
0.17
1.8
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
15
172
0.87
0.16
3.2
3.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
63
596
1.07
0.16
1.7
1.7
nmol/l
1080.3
1206.2
0.64
52
455
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
46
1.09
0.09
2.0
2.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
130
1272
1.04
0.09
1.8
2.0
pmol/l
86.8
93.4
0.78
68
639
(3041354) Potassium [Moles/volume] in Venous blood
5
47
1.06
0.09
2.0
2.8
mmol/l
4.5
4.1
—
5
47
(3035285) Chloride [Moles/volume] in Venous blood
5
47
1.06
0.09
2.0
2.8
mmol/l
105.4
105.4
—
5
47
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
61
0.82
0.08
1.0
1.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
5
61
0.82
0.08
1.0
1.2
nmol/l
1.0
0.8
—
5
50
(3014051) Protein [Presence] in Urine by Test strip
5
64
0.78
0.08
4.2
2.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
9
84
1.07
0.07
1.0
1.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
9
84
1.07
0.07
1.4
1.4
g/l
0.0
0.0
—
9
78
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
9
85
1.06
0.07
1.4
1.4
g/l
0.0
0.0
—
9
78
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
158
1.08
0.06
1.2
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
48
464
1.04
0.06
1.2
1.2
u/ml
0.7
1.6
1.01
13
121
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
10
92
1.09
0.03
1.4
1.5
g/l
0.1
0.0
—
10
85
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
103
1.07
0.02
1.3
1.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
174
1732
1.01
0.01
4.2
5.6
ug/l
1.9
3.1
1.19
158
1526
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
116
0.95
0.00
1.5
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
11
112
0.98
0.00
3.3
1.9
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
13
131
0.99
0.00
1.1
1.2
—
45.6
—
0
9
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
15
149
1.01
0.00
1.9
2.4
—
14.2
—
0
5
(3013512) EKG study
91
909
1.00
0.00
4.6
4.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
16.2
—
0
5
(21494755) Public health laboratory ask at order entry panel
7
72
0.97
0.00
1.1
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
8
0.00
0.00
0.0
4.1
—
13.6
—
0
8
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
14.0
—
6.4
—
0
5
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
78
0.90
0.00
1.1
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
108.4
—
0
5
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
89
0.90
0.00
6.3
4.7
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
8.6
—
0
5
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
4.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
14
140
1.00
0.00
3.5
4.0
u/ml
408.6
2701.9
—
9
125
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.6
—
0.8
—
0
5
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
60
1.00
0.00
1.7
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ILD_PIRFENIDONE – ILD medications: pirfenidone

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).